Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease
- PMID: 9770557
- DOI: 10.1056/NEJM199810153391603
Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease
Abstract
Background: In many patients with idiopathic Parkinson's disease, treatment with levodopa is complicated by fluctuations between an "off" period, when the medication is not working and the motor symptoms of parkinsonism are present, and an "on" period, when the medication is causing improved mobility, often accompanied by debilitating dyskinesias. In animal models of Parkinson's disease, there is overactivity in the subthalamic nucleus, and electrical stimulation of the subthalamic nucleus improves parkinsonism. We therefore sought to determine the efficacy and safety of electrical stimulation of the subthalamic nucleus in patients with Parkinson's disease.
Methods: We studied 24 patients with idiopathic Parkinson's disease in whom electrodes were implanted bilaterally in the subthalamic nucleus under stereotactic guidance with imaging and electrophysiologic testing of the location. Twenty were followed for at least 12 months. Clinical evaluations included the Unified Parkinson's Disease Rating Scale, a dyskinesia scale, and timed tests conducted before and after surgery, when patients were off and on medications.
Results: After one year of electrical stimulation of the subthalamic nucleus, the patients' scores for activities of daily living and motor examination scores (Unified Parkinson's Disease Rating Scale parts II and III, respectively) off medication improved by 60 percent (P<0.001). The subscores improved for limb akinesia, rigidity, tremor, and gait. In the testing done on medication, the scores on part III improved by 10 percent (P<0.005). The mean dose of dopaminergic drugs was reduced by half. The cognitive-performance scores remained unchanged, but one patient had paralysis and aphasia after an intracerebral hematoma during the implantation procedure.
Conclusions: Electrical stimulation of the subthalamic nucleus is an effective treatment for advanced Parkinson's disease. The severity of symptoms off medication decreases, and the dose of levodopa can be reduced with consequent reduction in dyskinesias.
Similar articles
-
Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.N Engl J Med. 2003 Nov 13;349(20):1925-34. doi: 10.1056/NEJMoa035275. N Engl J Med. 2003. PMID: 14614167
-
Bilateral subthalamic nucleus stimulation for Parkinson's disease.Neurol India. 2003 Mar;51(1):43-8. Neurol India. 2003. PMID: 12865514 Clinical Trial.
-
[Treatment of severe Parkinson disease with electric stimulation of the subthalamic nuclei].Ugeskr Laeger. 2000 Oct 9;162(41):5491-6. Ugeskr Laeger. 2000. PMID: 11068525 Danish.
-
[Unilateral subthalamic stimulation for early-stage Parkinson's disease].No To Shinkei. 2005 Jun;57(6):495-8. No To Shinkei. 2005. PMID: 16026045 Review. Japanese.
-
Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature.Neurosurgery. 2005 Jun;56(6):1313-21; discussion 1321-4. doi: 10.1227/01.neu.0000159714.28232.c4. Neurosurgery. 2005. PMID: 15918948 Review.
Cited by
-
A review of temporal interference, nanoparticles, ultrasound, gene therapy, and designer receptors for Parkinson disease.NPJ Parkinsons Dis. 2024 Oct 23;10(1):195. doi: 10.1038/s41531-024-00804-0. NPJ Parkinsons Dis. 2024. PMID: 39443513 Free PMC article. Review.
-
Vestibular Neurostimulation for Parkinson's Disease: A Novel Device-Aided Non-Invasive Therapeutic Option.J Pers Med. 2024 Aug 31;14(9):933. doi: 10.3390/jpm14090933. J Pers Med. 2024. PMID: 39338187 Free PMC article. Review.
-
The effect of growth hormone on motor findings and dendrite morphology in an experimental Parkinson's disease model.Anat Sci Int. 2024 Jul 31. doi: 10.1007/s12565-024-00790-6. Online ahead of print. Anat Sci Int. 2024. PMID: 39085683
-
Comparison of Apathy and Cognitive Symptoms in Pre- and Postoperative Period in Deep Brain Stimulation Surgery.Psychiatry Clin Psychopharmacol. 2023 Dec 1;33(4):238-245. doi: 10.5152/pcp.2023.23621. eCollection 2023 Dec. Psychiatry Clin Psychopharmacol. 2023. PMID: 38765847 Free PMC article.
-
Subthalamic nucleus synchronization between beta band local field potential and single-unit activity in Parkinson's disease.Physiol Rep. 2024 May;12(9):e16001. doi: 10.14814/phy2.16001. Physiol Rep. 2024. PMID: 38697943 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical